DE69900774D1 - Verwendung von topische präparationen mit glyceryl trinitrat und lanolin zur behandlung von erektilen funktionsstörungen - Google Patents

Verwendung von topische präparationen mit glyceryl trinitrat und lanolin zur behandlung von erektilen funktionsstörungen

Info

Publication number
DE69900774D1
DE69900774D1 DE69900774T DE69900774T DE69900774D1 DE 69900774 D1 DE69900774 D1 DE 69900774D1 DE 69900774 T DE69900774 T DE 69900774T DE 69900774 T DE69900774 T DE 69900774T DE 69900774 D1 DE69900774 D1 DE 69900774D1
Authority
DE
Germany
Prior art keywords
lanolin
glyceryl trinitrate
topical preparations
functional disorders
treating erectile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69900774T
Other languages
English (en)
Other versions
DE69900774T2 (de
Inventor
Colin Anthony Kemp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FUTURA MEDICAL DEVELOPMENTS LTD., GUILDFORD, SURRE
Original Assignee
FUTURA MEDICAL Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FUTURA MEDICAL Ltd filed Critical FUTURA MEDICAL Ltd
Publication of DE69900774D1 publication Critical patent/DE69900774D1/de
Application granted granted Critical
Publication of DE69900774T2 publication Critical patent/DE69900774T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gynecology & Obstetrics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Prostheses (AREA)
  • Drying Of Semiconductors (AREA)
  • Signal Processing For Digital Recording And Reproducing (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Cosmetics (AREA)
DE69900774T 1998-01-30 1999-01-28 Verwendung von topische präparationen mit glyceryl trinitrat und lanolin zur behandlung von erektilen funktionsstörungen Expired - Fee Related DE69900774T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9802078.7A GB9802078D0 (en) 1998-01-30 1998-01-30 Preparation for treatment of erectile dysfunction
PCT/GB1999/000288 WO1999038506A2 (en) 1998-01-30 1999-01-28 Use of topical preparations of glyceryl trinitrate and lanolin for the treatment of erectile dysfunction

Publications (2)

Publication Number Publication Date
DE69900774D1 true DE69900774D1 (de) 2002-02-28
DE69900774T2 DE69900774T2 (de) 2002-08-14

Family

ID=10826219

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69900774T Expired - Fee Related DE69900774T2 (de) 1998-01-30 1999-01-28 Verwendung von topische präparationen mit glyceryl trinitrat und lanolin zur behandlung von erektilen funktionsstörungen

Country Status (18)

Country Link
EP (2) EP0934744A1 (de)
JP (1) JP2002501893A (de)
KR (1) KR100595413B1 (de)
CN (1) CN1292691A (de)
AT (1) ATE211650T1 (de)
AU (1) AU747085B2 (de)
BR (1) BR9908358A (de)
CA (1) CA2319202A1 (de)
DE (1) DE69900774T2 (de)
DK (1) DK1049461T3 (de)
ES (1) ES2169942T3 (de)
GB (1) GB9802078D0 (de)
HK (1) HK1033647A1 (de)
ID (1) ID26132A (de)
IL (2) IL137561A0 (de)
NZ (1) NZ506580A (de)
PT (1) PT1049461E (de)
WO (1) WO1999038506A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002078580A1 (en) 2001-03-30 2002-10-10 Futura Medical Developments Limited Condom with an erectogenic composition
GB0417675D0 (en) * 2004-08-09 2004-09-08 Futura Medical Dev Ltd Composition for promoting vascular smooth muscle relaxation
GB0602224D0 (en) 2006-02-03 2006-03-15 Futura Medical Dev Ltd Composition for promoting vascular smooth muscle relaxation
GB201121204D0 (en) 2011-12-09 2012-01-18 Lrc Products A pack containing a condom
CN104161617A (zh) * 2014-08-29 2014-11-26 蔺莹莹 一种新型避孕套及其制备方法
WO2019114705A1 (zh) 2017-12-13 2019-06-20 上海小午医药科技有限公司 一种用于预防或治疗与egfr被抑制相关疾病的方法
CN111989095A (zh) 2018-04-16 2020-11-24 上海岸阔医药科技有限公司 预防或治疗肿瘤疗法副作用的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5572108A (en) * 1978-11-27 1980-05-30 Sanwa Kagaku Kenkyusho:Kk Preparation for transcutaneous administration, composed mainly of nitroglycerine
US4450175A (en) * 1982-09-23 1984-05-22 Warshaw Thelma G Method and compositions for treating acne
IE54286B1 (en) * 1983-01-18 1989-08-16 Elan Corp Plc Drug delivery device
EP0266921A3 (de) * 1986-11-06 1990-05-30 Shiseido Company Limited Mittel zur Linderung von Hautreizungen und Zusammensetzung davon
US4829991A (en) * 1987-01-06 1989-05-16 Medical Engineering Corp. Method and device for stimulating an erection
LU87410A1 (fr) * 1988-12-20 1990-07-10 Cird Composition cosmetique ou pharmaceutique contenant des microspheres de polymeres ou de corps gras chargees d'au moins un produit actif
JPH02200633A (ja) * 1989-01-27 1990-08-08 Akamatsu Shoji Kk 血管拡張剤
BR9203277A (pt) * 1992-08-21 1994-03-01 Cesar Roberto Dias Nahoum Utilizaccao de drogas eretogenicas e respectivas metodologias de aplicacao
US5698589A (en) * 1993-06-01 1997-12-16 International Medical Innovations, Inc. Water-based topical cream containing nitroglycerin and method of preparation and use thereof
US5565466A (en) * 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response
RU2036644C1 (ru) * 1994-01-05 1995-06-09 Олег Борисович Лоран Средство для нормализации половой потенции мужчин

Also Published As

Publication number Publication date
KR100595413B1 (ko) 2006-07-03
EP1049461B1 (de) 2002-01-09
KR20010040488A (ko) 2001-05-15
IL137561A (en) 2006-12-31
PT1049461E (pt) 2002-07-31
IL137561A0 (en) 2001-07-24
ID26132A (id) 2000-11-23
WO1999038506A2 (en) 1999-08-05
EP1049461A2 (de) 2000-11-08
ES2169942T3 (es) 2002-07-16
CN1292691A (zh) 2001-04-25
CA2319202A1 (en) 1999-08-05
EP0934744A1 (de) 1999-08-11
BR9908358A (pt) 2002-12-31
WO1999038506A3 (en) 1999-09-30
ATE211650T1 (de) 2002-01-15
AU747085B2 (en) 2002-05-09
DE69900774T2 (de) 2002-08-14
GB9802078D0 (en) 1998-03-25
AU2289899A (en) 1999-08-16
JP2002501893A (ja) 2002-01-22
DK1049461T3 (da) 2002-04-15
HK1033647A1 (en) 2001-09-14
NZ506580A (en) 2003-05-30

Similar Documents

Publication Publication Date Title
EP0801946A3 (de) Verwendung von Salicin als antiirritativer Wirkstoff in kosmetischen und topischen dermatologischen Zubereitungen
DE69733132D1 (de) Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen
ATE229502T1 (de) Arylsulfonamide und analoga und ihre verwendung zur behandlung von neurodegenerativen erkrankungen
DE69521700D1 (de) Mittel und methoden zur behandlung von plaque-krankheiten
ATE184792T1 (de) 2-bromomelatonin zur behandlung von schlafstörungen
ATE185971T1 (de) Kombinationspräparat zur behandlung hypogonadaler männer sowie männern mit hypophysenerkrankungen
DE69830728D1 (de) Arzneimittel zur behandlung von häufigem wasserlassen und harninkontinenz
ATE186834T1 (de) Verwendung von wirksamen mengen von aktiven stoffen zur behandlung von mischhaut
DE69907577D1 (de) Entzündungshemmende Zusammensetzung
DE69631478D1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
WO2000002544A3 (en) Use of piperine for treating skin pigmentation disorders
DE69825279D1 (de) Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
DE3671365D1 (de) Topische anwendung des 3-phenylacetylamino-2,6-piperidindions zur behandlung von hautfalten und hyperpigmentierung.
DE69900774D1 (de) Verwendung von topische präparationen mit glyceryl trinitrat und lanolin zur behandlung von erektilen funktionsstörungen
DE69229780D1 (de) Zusammensetzung und methode zur behandlung von störungen in form von depigmentierung
EP0801945A3 (de) Verwendung von Glucosiden von Ferulasäure als antiirritativer Wirkstoff in kosmetischen und topischen dermatologischen Zubereitungen
DE69932922D1 (de) Verwendung von alkansäuren-enthaltenden zusammensetzungen zur behandlung von nagelpilz-erkrankungen
DE69822276D1 (de) Kräuter formulierung mit therapeutischer und kosmetischer verwendung zur behandlung von allgemeinen hauterkrankungen
ATE137967T1 (de) Verwendung von ketorolac zur behandlung von periodontitis
ATE137955T1 (de) Verwendung von 1,2-dipalmitoyl-l-alpha- phosphatidyl-n,n-dimethylethanilamine in dermatologischen und kosmetischen zusammensetzungen
ATE216884T1 (de) Verwendung von sulbutiamin zur behandlung von psychomotorischen oder psychointellektuellen beschwerden
DK0836853T3 (da) Anvendelse af bradykinin-antagonister til fremstilling af lægemidler til behandling og forebyggelse af Alzheimers sygdom
DE69717200D1 (de) Arzneimittel und Kosmetika enthaltend Zizyphus-spina-christi Extrakte
DE59000311D1 (de) Verwendung von suramin und physiologisch vertraeglichen derivaten davon, gegebenenfalls in kombination mit anti-androgenen mitteln zur herstellung von arzneimitteln zur behandlung des humanen prostatakarzinoms.
DE50000562D1 (de) Mittel zur behandlung von pigmentierungsstörungen

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: FUTURA MEDICAL DEVELOPMENTS LTD., GUILDFORD, SURRE

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee